Identification of a 17beta-hydroxysteroid dehydrogenase type 12 pseudogene as the source of a highly restricted BALB/c Meth A tumor rejection peptide.
about
Pseudogene in cancer: real functions and promising signature.Identification of Hydroxysteroid (17β) dehydrogenase type 12 (HSD17B12) as a CD8+ T-cell-defined human tumor antigen of human carcinomas17β Hydroxysteroid dehydrogenase type 12 (HSD17B12) is a marker of poor prognosis in ovarian carcinoma.
P2860
Identification of a 17beta-hydroxysteroid dehydrogenase type 12 pseudogene as the source of a highly restricted BALB/c Meth A tumor rejection peptide.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Identification of a 17beta-hyd ...... eth A tumor rejection peptide.
@ast
Identification of a 17beta-hyd ...... eth A tumor rejection peptide.
@en
type
label
Identification of a 17beta-hyd ...... eth A tumor rejection peptide.
@ast
Identification of a 17beta-hyd ...... eth A tumor rejection peptide.
@en
prefLabel
Identification of a 17beta-hyd ...... eth A tumor rejection peptide.
@ast
Identification of a 17beta-hyd ...... eth A tumor rejection peptide.
@en
P2093
P2860
P1476
Identification of a 17beta-hyd ...... eth A tumor rejection peptide.
@en
P2093
Albert B DeLeo
Andrea Gambotto
Andreas Albers
Carmen Visus
Donald F Hunt
Ettore Appella
Grzegorz Dworacki
Jose I Mayordomo
Ornella Pagliano
Ronald C Hendrickson
P2860
P2888
P304
P356
10.1007/S00262-009-0730-7
P577
2009-06-27T00:00:00Z
P5875
P6179
1007905477